About Us

At a Glance

We are a global company committed to innovating for a healthier world. We create the instruments, tests, software and services used by scientists, researchers and clinicians to address the most critical challenges across science and healthcare.

190 countries

in operation



5.0 billion

in revenue

80+ years

of innovations


Driving positive outcomes through precision diagnostics

With $2.9 billion in revenue for 2021, we are s a major player in the in vitro diagnostics market. Operating on a global scale, we offer innovative and complete solutions, including instruments, reagents, automation, services and software, designed to serve multiple end users and needs.

RH visual

Reproductive Health

We believe all expectant mothers should have a healthy pregnancy and all babies should have a better start in life. To do so, we provide laboratories and clinics with complete screening solutions that enable them to identify a wide range of disorders from early in the pregnancy to the first few weeks of birth.

We are the global leader in prenatal and newborn screening. Last year, 140 million of our tests were used to screen babies for various disorders. To date, more than 735 million babies have been tested for life-threatening diseases using our newborn screening tools.

Rectangle 281


EUROIMMUN, is a leading manufacturer of medical laboratory diagnostics worldwide and stands for innovation. The company commands extensive know-how and a broad technology base allowing in-house research, development and production to optimally meet the customer needs.

Laboratories in over 140 countries rely on our test systems as well as automation and software solutions for the diagnostics of autoimmune and infectious diseases as well as allergies, and to perform genetic analyses.


Applied Genomics

Our optimized, automated solutions are designed to eliminate the challenges associated with genomic and proteomic analysis by providing labs with complete, single-source solutions encompassing everything from sample to solution.

We are working closely with laboratories around the world to deliver the SARS-CoV-2 detection, screening and surveillance solutions they need, when they need them. Our nucleic acid isolation, automation, real-time PCR and NGS library preparation solutions allow labs to rapidly respond to their SARS-CoV-2 challenges with flexible, single-source workflows.

(SCIENCE) Scientists are certain activities on experimental scie

Learn more about our portfolio

Spin gif